164.10
price up icon0.20%   +0.32
 
loading

Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten

Krystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Up 5.7% in April - MarketBeat

pulisher
MarketBeat

Krystal Biotech: VYJUVEK's Blockbuster Potential In Gene Therapy For DEB - citybiz

pulisher
citybiz

3 High Insider Ownership US Stocks With Up To 55% Revenue Growth - Simply Wall St

pulisher
Simply Wall St

Krystal Biotech, Inc. (NASDAQ:KRYS) Sees Large Growth in Short Interest - Defense World

pulisher
Defense World

First Turn Management LLC Acquires Shares of 242,185 Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

Krystal Biotech: VYJUVEK's Blockbuster Potential In Gene Therapy For DEB (NASDAQ:KRYS) - Seeking Alpha

pulisher
Seeking Alpha

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference - WICZ

pulisher
WICZ

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference

pulisher
GlobeNewswire Inc.

Krystal Biotech, Inc. (NASDAQ:KRYS) Holdings Reduced by Russell Investments Group Ltd. - MarketBeat

pulisher
MarketBeat

Krystal Biotech's (NASDAQ:KRYS) Earnings Might Be Weaker Than You Think - Simply Wall St

pulisher
Simply Wall St

Where are the Opportunities in (KRYS) - Stock Traders Daily

pulisher
Stock Traders Daily

Cantor Fitzgerald Equities Analysts Raise Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

pulisher
Defense World

Victory Capital Management Inc. Sells 36,608 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

Cantor Fitzgerald Analysts Boost Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

Q3 2024 EPS Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) Boosted by William Blair - Defense World

pulisher
Defense World

Victory Capital Management Inc. Sells 36608 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

pulisher
Defense World

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by New York Life Investment Management LLC - Defense World

pulisher
Defense World

Q3 2024 EPS Estimates for Krystal Biotech, Inc. Boosted by Analyst (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

New York State Common Retirement Fund Sells 7,091 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Los Angeles Capital Management LLC - Defense World

pulisher
Defense World

HC Wainwright Brokers Boost Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World

pulisher
Defense World

Krystal Biotech, Inc. (NASDAQ:KRYS) Forecasted to Post Q2 2024 Earnings of $0.37 Per Share - MarketBeat

pulisher
MarketBeat

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

pulisher
GlobeNewswire Inc.

Krystal Biotech Reveals Eye Treatment Vector at ARVO 2024 - TipRanks.com - TipRanks

pulisher
TipRanks

TimesSquare Capital Management LLC Buys 127,435 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

Krystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat

pulisher
MarketBeat

Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Company News for May 7, 2024 - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions Set ... - GuruFocus.com

pulisher
GuruFocus.com

Krystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat

pulisher
MarketBeat

Krystal Biotech's Battle to Scale VYJUVEK Production Amid Regulatory Hurdles and Soaring Demand - TipRanks.com - TipRanks

pulisher
TipRanks

Earnings call: Krystal Biotech sees strong Q1 growth, plans global expansion - Investing.com India

pulisher
Investing.com India

Krystal Biotech (NASDAQ:KRYS) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

pulisher
MarketBeat

Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024 - Yahoo Finance

pulisher
Yahoo Finance

Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates

pulisher
Zacks Investment Research

Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates - Zacks Investment Research

pulisher
Zacks Investment Research

Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates - Investing.com South Africa

pulisher
Investing.com South Africa

Krystal Biotech (NASDAQ:KRYS) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

pulisher
MarketBeat

Krystal Biotech (KRYS) Set to Announce Quarterly Earnings on Monday - Defense World

pulisher
Defense World

Why Krystal Biotech (KRYS) Might Surprise This Earnings Season

pulisher
Zacks Investment Research

Why Krystal Biotech (KRYS) Might Surprise This Earnings Season - Yahoo Finance

pulisher
Yahoo Finance

How the (KRYS) price action is used to our Advantage - Stock Traders Daily

pulisher
Stock Traders Daily

Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

pulisher
GlobeNewswire Inc.

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024

pulisher
GlobeNewswire Inc.

Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround

pulisher
Zacks Investment Research

Jennison Associates LLC Has $89.86 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - MarketBeat

pulisher
MarketBeat

Krystal Biotech moves to next step in clinical trial - Pittsburgh Business Times

pulisher
Pittsburgh Business Times

Krystal Biotech moves to next step in clinical trial - The Business Journals

pulisher
The Business Journals

Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable - MSN

pulisher
MSN
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Kapitalisierung:     |  Volumen (24h):